Loading clinical trials...
Loading clinical trials...
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
Conditions
Interventions
COVID-19 Androgen Sensitivity Test (CoVAST)
Locations
2
United States
Applied Biology, Inc
Irvine, California, United States
University of California, Irvine - Dermatology Clinical Research
Irvine, California, United States
Start Date
August 13, 2020
Primary Completion Date
December 1, 2021
Completion Date
December 1, 2023
Last Updated
May 8, 2024
NCT07189936
NCT04525716
NCT03188796
NCT04527315
NCT05013632
NCT06355232
Lead Sponsor
University of California, Irvine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions